{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T20:54:25Z","timestamp":1773262465424,"version":"3.50.1"},"reference-count":8,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["Clin Nucl Med"],"published-print":{"date-parts":[[2024,3]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Autosomal dominant polycystic kidney disease (ADPKD) manifests as multiple cysts in the kidneys and liver but can also present with musculoskeletal and cardiovascular abnormalities. ADPKD patients are at increased risk for renal cell carcinoma development. We show the FDG PET\/CT findings in a patient with renal cell carcinoma secondary to ADPKD and complicated by worsening pulmonary metastasis. The primary renal tumor shows intense FDG uptake despite no suspicious features with contrast CT.<\/jats:p>","DOI":"10.1097\/rlu.0000000000005059","type":"journal-article","created":{"date-parts":[[2024,1,25]],"date-time":"2024-01-25T18:04:21Z","timestamp":1706205861000},"page":"e131-e133","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Metastatic Renal Cell Carcinoma in a Patient With Autosomal Dominant Polycystic Kidney Disease"],"prefix":"10.1097","volume":"49","author":[{"given":"Wyatt M.","family":"Rumrill","sequence":"first","affiliation":[{"name":"Washington University School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David H.","family":"Ballard","sequence":"additional","affiliation":[{"name":"Mallinckrodt Institute of Radiology, Washington University School of Medicine, St Louis, MO."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2024,1,23]]},"reference":[{"key":"bib1-20250621","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/S0272-6386(12)80051-5","article-title":"Autosomal dominant polycystic kidney disease\u2014more than a renal disease","volume":"16","year":"1990","journal-title":"Am J Kidney Dis"},{"key":"bib2-20250621","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1681\/ASN.V491661","article-title":"Renal cell carcinoma in autosomal dominant polycystic kidney disease","volume":"4","year":"1994","journal-title":"J Am Soc Nephrol"},{"key":"bib3-20250621","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.urology.2009.02.078","article-title":"Prevalence of renal cell carcinoma in patients with autosomal dominant polycystic kidney disease and chronic renal failure","volume":"74","year":"2009","journal-title":"Urology"},{"key":"bib4-20250621","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1159\/000351049","article-title":"Autosomal dominant polycystic kidney disease: prevalence of renal neoplasias in surgical kidney specimens","volume":"123","year":"2013","journal-title":"Nephron Clin Pract"},{"key":"bib5-20250621","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.ejrex.2004.05.003","article-title":"Renal cell carcinoma (RCC) in autosomal dominant polycystic kidney disease (ADPKD)","volume":"51","year":"2004","journal-title":"Eur J Radiol Extra"},{"key":"bib6-20250621","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/S0022-5347(17)55621-9","article-title":"Renal cell carcinoma in polycystic kidneys: case report and review of literature","volume":"124","year":"1980","journal-title":"J Urol"},{"key":"bib7-20250621","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/S0022-5347(17)57991-4","article-title":"Renal carcinoma associated with polycystic kidneys: occurrence after chronic hematuria and hypertension","volume":"118","year":"1977","journal-title":"J Urol"},{"key":"bib8-20250621","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S1078-1439(01)00185-5","article-title":"Mode of presentation of renal cell carcinoma provides prognostic information","volume":"7","year":"2002","journal-title":"Urol Oncol"}],"container-title":["Clinical Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000005059","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,21]],"date-time":"2025-06-21T19:02:26Z","timestamp":1750532546000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000005059"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,23]]},"references-count":8,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/rlu.0000000000005059","relation":{},"ISSN":["1536-0229","0363-9762"],"issn-type":[{"value":"1536-0229","type":"electronic"},{"value":"0363-9762","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1,23]]}}}